FDA OKs LabCorp to make at-home COVID-19 kits available through retail

 

• The FDA has granted Emergency Use Authorization (EUA) for Laboratory Corporation of America's (NYSE:LH) Pixel by LabCorp COVID-19 Test Home Collection Kit to become the first to be available over the counter without requiring a prescription. This approval will enable the company to potentially distribute the kit through retail channels.
• The kit allows consumers to self-collect their sample in the privacy of their own home, which helps minimize transmission of the virus. Users then send the sample for processing at LabCorp.
• Upon purchase, users register their Pixel COVID-19 collection kit and follow the instructions included. Test results are securely delivered to the consumer via the Pixel by LabCorp portal.
• A healthcare provider will counsel consumers who test positive to assist with treatment and actions.
• https://seekingalpha.com/news/3643167-labcorp-receives-fda-authorization-to-make-home-covidminus-19-kits-available-through-retail